ENO Breathe is currently only available for patients who have been medically assessed by a participating healthcare services in England.

Patients are referred via medical criteria to ensure safety, suitability, and clinical appropriateness. 

The programme is open to patients who are struggling with ongoing symptoms of breathlessness since getting Covid-19, and now also those with other similar post-viral symptom presentation.  

In parallel, ENO Breathe is being delivered to patients with COPD and asthma in Greater Manchester and North West London as part of an initial Test & Learn phase for these new patient groups.